We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,244 results
  1. Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study

    Purpose

    Pharmacodynamic drug-drug interactions (PD DDIs) may influence the safety of non-vitamin K antagonist oral anticoagulants (NOACs), but the...

    Maxim Grymonprez, Andreas Capiau, ... Lies Lahousse in Cardiovascular Drugs and Therapy
    Article 06 November 2023
  2. Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat

    Vericiguat is an oral soluble guanylate cyclase stimulator and enhances the cyclic guanosine monophosphate pathway independently of nitric oxide as...

    Achim Fritsch, Michaela Meyer, ... Corina Becker in Clinical Pharmacokinetics
    Article Open access 25 June 2024
  3. Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone

    (R,S)-methadone ((R,S)-MTD) is a µ-opioid receptor (MOR) agonist comprised of (R)-MTD and (S)-MTD enantiomers. (S)-MTD is being developed as an...

    Marjorie R. Levinstein, Paulo A. De Oliveira, ... Michael Michaelides in Molecular Psychiatry
    Article 25 December 2023
  4. Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

    Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis observed in critically ill patients. It is associated with high...

    Emmanuel Novy, Claire Roger, ... Menino Osbert Cotta in Critical Care
    Article Open access 20 November 2023
  5. Pharmacokinetics and Pharmacodynamic of Alpelisib

    Advanced breast cancers are frequently hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative. Some of them...

    Bernard Royer, Courèche Guillaume Kaderbhaï, Antonin Schmitt in Clinical Pharmacokinetics
    Article 12 January 2023
  6. Antiseizure Medication Interactions A Clinical Guide

    This significantly revised fourth edition provides a practically orientated guide to interactions associated with antiseizure medications. It...

    Philip N. Patsalos
    Book 2022
  7. Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance

    Natural products, also referred to as dietary supplements, complementary and alternative medicines, and health or food supplements are widely used by...

    Wai-Jo Jocelin Chan, Jeffry Adiwidjaja, ... Joanna E. Harnett in Cancer Chemotherapy and Pharmacology
    Article Open access 27 January 2023
  8. Quantitative Prediction of Adverse Event Probability Due to Pharmacokinetic Interactions

    Introduction

    Iatrogeny due to drug–drug interactions is insufficiently documented, due to the high number of possible combinations.

    Objective ...
    Michel Tod, Thomas Rodier, Marine Auffret in Drug Safety
    Article 23 June 2022
  9. Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients

    At least 170 approved drugs are linked to QT prolongation, which can lead to serious adverse drug reactions (ADRs), such as Torsade de Pointes (TdP)....

    Gudrun Hefner, Martina Hahn, ... Ansgar Klimke in Journal of Neural Transmission
    Article 08 January 2021
  10. A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia

    Introduction

    Hair loss is driven by multiple factors, including genetics. Androgenetic alopecia (AGA) is a condition in which treatments necessitate...

    Heesun Kim, Choongho Ryu, ... Juhee Kim in Advances in Therapy
    Article 04 June 2024
  11. Potentially Harmful Drug–Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study

    Background

    Cardiovascular diseases are responsible for a significant proportion of mortalities worldwide. Elderly patients are the most affected by...

    Abdulrahman Kalash, Aly Abdelrahman, ... Yousuf Al Suleimani in Drugs - Real World Outcomes
    Article Open access 13 May 2023
  12. Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors

    Purpose

    Talazoparib is an inhibitor of the poly (ADP-ribose) polymerase (PARP) family of enzymes and is FDA-approved for patients with (suspected)...

    Arjun Mittra, Geraldine H. O’ Sullivan Coyne, ... Alice P. Chen in Cancer Chemotherapy and Pharmacology
    Article Open access 27 November 2023
  13. Mechanistic Pharmacokinetic/Pharmacodynamic Modeling in Support of a Patient-Convenient, Longer Dosing Interval for Carfilzomib, a Covalent Inhibitor of the Proteasome

    Background

    Carfilzomib is an irreversible second-generation proteasome inhibitor that has a short elimination half-life but much longer...

    Marc R. Yago, Khamir Mehta, ... Vijay V. Upreti in Clinical Pharmacokinetics
    Article Open access 18 April 2023
  14. Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants

    Purpose

    Polypharmacy is a frequent situation in older adults that increases the risk of drug-drug interactions (DDIs), both pharmacokinetic (PK) and...

    Théodore Decaix, Kenza Kemache, ... Éric Pautas in Aging Clinical and Experimental Research
    Article Open access 22 May 2024
  15. Interactions of Antiretroviral Drugs with Food, Beverages, Dietary Supplements, and Alcohol: A Systematic Review and Meta-analyses

    Multiple factors may affect combined antiretroviral therapy (cART). We investigated the impact of food, beverages, dietary supplements, and alcohol...

    Agnieszka Wiesner, Magdalena Skrońska, ... Paweł Paśko in AIDS and Behavior
    Article Open access 01 November 2022
  16. Pressure response to fluid challenge administration in hypotensive surgical patients: a post-hoc pharmacodynamic analysis of five datasets

    In this study we evaluated the effect of fluid challenge (FC) administration in elective surgical patients with low or normal blood pressure....

    Antonio Messina, Davide Colombo, ... Maurizio Cecconi in Journal of Clinical Monitoring and Computing
    Article 05 October 2022
  17. Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone

    Background

    The prevalence and therapeutic effects of the use of herbal remedies for chronic liver diseases make the combined administration of herbal...

    Tun-Pin Hsueh, Tung-Hu Tsai in BMC Complementary Medicine and Therapies
    Article Open access 15 August 2020
  18. Factors that Impact the Pharmacokinetic and Pharmacodynamic Effects of Cannabis: a Review of Human Laboratory Studies

    Purpose of Review

    With cannabis legalization expanding throughout the world, an unprecedented number of people now have access to legal cannabis. This...

    C. Austin Zamarripa, Ryan Vandrey, Tory R. Spindle in Current Addiction Reports
    Article 26 July 2022
  19. Pharmacokinetic drug interactions of oral anticancer drugs

    Over the past 20 years, oral anticancer drugs have increased in importance for the treatment of solid tumors and hematological diseases....

    Julia Gampenrieder Satory in memo - Magazine of European Medical Oncology
    Article 24 October 2022
  20. Drug–drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care

    Background

    Direct oral anticoagulants (DOACs) can be involved in clinical relevant drug–drug interactions (DDIs) which may compromise safe and...

    Andreas Capiau, Els Mehuys, ... Koen Boussery in International Journal of Clinical Pharmacy
    Article 29 November 2022
Did you find what you were looking for? Share feedback.